OrganoClick AB (SE:ORGC)
:ORGC
Want to see SE:ORGC full AI Analyst Report?
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr0.33 - kr2.18
Previous CloseN/A
Volume11.05K
Average Volume (3M)87.89K
Market Cap
kr54.56M
Enterprise Valuekr129.38M
Total Cash (Recent Filing)kr3.05M
Total Debt (Recent Filing)kr77.43M
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Jul 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding110,003,010
10 Day Avg. Volume18,569
30 Day Avg. Volume87,893
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
Bulls Say, Bears Say
Bulls Say
Improving Operating Cash FlowOperating cash flow turning positive signals the company is beginning to convert operations into cash, reducing near-term liquidity strain. If sustained, this improves ability to fund working capital and modest investments without immediate reliance on new equity or debt refinancing.
Sizeable Asset BaseA sizable asset base provides capacity to support scale-up, secures creditor confidence and can be deployed as collateral or invested in commercialization. Over months, assets help preserve optionality for growth, restructuring or funding if operations are stabilized.
Sustainable Product PlatformA focus on bio-based replacements for fossil chemicals aligns with durable regulatory and customer trends toward sustainability. Structural demand for greener textile and wood treatments can support long-term adoption and provide differentiation versus incumbent chemistries.
Bears Say
Declining Revenue TrendA multi-year pattern of revenue decline constrains scale economies and weakens bargaining power with customers and suppliers. Continued top-line contraction hampers margin recovery, delays path to profitability and reduces internal funding for R&D or commercialization.
Very High LeverageExtremely high debt-to-equity magnifies financial risk, limiting strategic flexibility. Over the medium term this raises refinancing and covenant risks, increases interest burden, and can force asset sales or equity issuance that dilute shareholders if cash generation falters.
Weak Profitability And MarginsDeep negative net margins and low gross margins indicate fragile earnings power and poor unit economics. Persisting losses erode the equity cushion, impede reinvestment and make the company reliant on external funding until structural margin improvement is achieved.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.33 and its highest was kr2.18 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr54.56M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is Jul 17, 2026 which is in 37 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on May 06, 2026. The company reported -kr0.015 earnings per share for the quarter, beating the consensus estimate of -kr0.02 by kr0.005.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 110,003,010 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.015 in its last earnings report, beating expectations of -kr0.02. Following the earnings report the stock price went up 6.371%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―